BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 9285199)

  • 1. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.
    Simmons WD; Rayhill SC; Sollinger HW
    Drug Saf; 1997 Aug; 17(2):75-92. PubMed ID: 9285199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil: a review of its use in the management of solid organ transplantation.
    Bardsley-Elliot A; Noble S; Foster RH
    BioDrugs; 1999 Nov; 12(5):363-410. PubMed ID: 18031189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
    Fulton B; Markham A
    Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil in kidney transplantation.
    Lui SL; Halloran PF
    Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):508-13. PubMed ID: 8978998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.
    Young M; Plosker GL
    Pharmacoeconomics; 2002; 20(10):675-713. PubMed ID: 12162756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
    Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil.
    Sollinger HW
    Kidney Int Suppl; 1995 Dec; 52():S14-7. PubMed ID: 8587275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Mycophenolate Mofetil (Cellcept) in renal transplantation.
    Vanrenterghem Y
    Nephron; 1997; 76(4):392-9. PubMed ID: 9274835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk.
    Chatel MA; Larkin DF
    Am J Ophthalmol; 2010 Aug; 150(2):179-84. PubMed ID: 20570235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mycophenolate mofetil in liver transplant recipients.
    Detry O; de Roover A; Delwaide J; Meurisse M; Honoré P
    Expert Opin Pharmacother; 2003 Nov; 4(11):1949-57. PubMed ID: 14596648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of rheumatoid arthritis with mycophenolate mofetil.
    Goldblum R
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S117-9. PubMed ID: 8324935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil for the transplanted kidney?
    Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of mycophenolate mofetil in kidney transplantation].
    Hrvacevic R; Ignjatovic Lj; Vavic N
    Vojnosanit Pregl; 2001; 58(4):415-9. PubMed ID: 11712223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.